CYTOGENETICAL AND IMMUNOMORPH OLOGICAL STUDY OF CHLORPROMAZINE EFFECT ON HUMAN LYMPHOCYTE CULTURES IN VITRO by Boneva, D.
Phenothiazine neuroleptics are the subject of a great number of studies 
aimed at estimating their mutagenic threat for man. For the purpose outlined 
a var ie ty of test-systems are employed, such as genie mutations of microor-
ganisms wi th or without beforehand metabolite (or wi th hepatic homogenate) 
act ivat ion of the drug under test w i t h i n the organism of mammals; genetic 
(point) mutations in Drosophila melanogaster; dominant lethal mutations in 
mammals; cytogenetic investigation of bone marrow, tissue and cell cultures 
in mammals; mutagenesis of cultures from specially treated cel l strains; mic-
ronuclear test in mammals. 
I n the treatment of humans i t is possible to assay both mutagenic action 
of the medicament, through cytogenetic study of lymphocyte cultures, and 
its teratogenic action i n case of eventual ly observed monstruosities i n the off-
spring. Under experimental conditions, the cytogenetic investigation of l ym-
phocyte cultures treated i n vi t ro is very extensively used. 
According to survey data, submitted ty Y . L . Shapiro et a l (1972—31) , 
a teratogenic effect was recorded twice i n the course of stelazine (trifluope-
razine) treatment of pregnant women ( B . Horner and G . H a l l — 1973). Also, 
reports are avai lable on chromosome aberrations among individuals undergo-
ing stelazine treatment ( H . Jenkins , 1970 — 45). However, on drosophila 
( I . A . Rappoport et a l , 1971 — 2 1 ) and on lymphocyte cultures ( V . S . Zhur-
kov, 1975 — 1 2 ) no mutagenic ac t i v i t y of the preparation has been found. 
I n the opinion of some authors ( K . Petersen et a l , 1973 — 53) trifluproma-
zine causes dominant lethal mutations in mice, whereas according to others 
( V . R a y et a l , 1973 — 54) on the basis of complex investigation of the prepara-
tion, mutagenic ac t iv i ty is detectable neither in mice insofar as dominant 
lethal mutations and chromosome aberrations in bone marrow are concerned, 
nor i n salmonella wi th metabolite act ivat ion and in human lymphocyte cultures. 
Reports on mazheptil (thio- /pro/ perazine) c la im an insignificant increase 
i n chromosome breaks in the course of treatment (M. Krachunova, 1975— 16), 
whi ls t in lymphocyte cultures, i n vi t ro , i t exerts a mi ld cytogenetical effect, 
manifested at concentrations exceeding the therapeutical dose 50—100 times 
(12). On drosphila no mutagenicity is recorded (21), whi le in mice bone mar-
row it is not cytogenetically active (L^Chioreame et a l , 1967 — cited by 3 1 ; 
Y . A . Revazova et a l , 1975—22). Also, no point mutations on salmonella are 
found, although dominant lethal mutations in mice, as wel l a sce r ta in increase 
in chromosome breaks in lymphocyte cultures, treated in vi t ro , a re .es - , 
tablished, warranting its classification as a weak mutagen (22)1 
Perphenazine, according to some authors ( J . Nielsen et a l , 1969 — 51) 
augments chromosome deletions among treated individuals , wh ich is denied 
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by others (M. Cohen e t a l , 1972 — 38). On drosophila etaperazine (perphenazine) 
is manifested as a medium strong mutagen ( I . A . Rappoport e t a l , 1965—20) 
Phrenolon (metaphenazine) and propazine (promazine) do not prove mu-
tagenically active on drosophila and lymphocyte cultures (21 , 12). 
Pipolfen (promethazine) which has a marked mutagenic a c t i v i t y for dro-
sophila, failed to manifest a s imilar ac t iv i ty on lymphocyte cultures (12). 
Treatment wi th thioridazine and fluphenazine does not account for in-
crease in chromosome aberrations in the lymphocytes (M. Cohen et a l , 1969 — 
36). Fluphenazine (liogen) does not produce mutations on drosophila (21). 
S i m i l a r l y , no mutations on drosophila are observed in the course of ex-
periments wi th neuleptil (propericyasine), randolectil (butylperazine) and te-
ralen (methylpromazine) ( L . M . Filip®va et a l , 1975 — 26). 
Chlorcisine (diethylaminopropyl-chlor-phenothiazine) exerts a strong mu-
tagenic effect on drcsophila (20). 
Chlorpromazine (CP) — dimethylaminopropyl-chlor-phenothiazine — known 
also under the trademark names largact i l , plegomazine, chlorazine, megafen, 
thorazine, aminazine etc — is a neuroleptic most frequently and widely used 
in the medical practice, and also, the subject of numerous researches. 
As regards megaphen (49) and aminazine (21), no mutagenic a c t i v i t y 
on drosophila whatever is established. 
C P administrat ion to pregnant rats produces abortions and underdevelop-
ment of the fetus ( 1 . Chambon, 1955); administered to female and male mates 
it reduces fer t i l i ty whi le the progeny shows poor development ( B . and L . Doty, 
1963). I n mice, however, C P does not account for lethal mutations ( S . Epstein 
et a l , 1968 — 40). According to more recent data, in mice it inhibits the ferti-
l ized ovum implantation and methionine transport towards blastocyte ( R . Bor-
land et a l , 1975 — 33). 
C P at dose 1—20 mcg/ml, administered over a period of 24 hrs on cell 
cultures from Chinese hamster, doesn't cause chromosome aberrations ( F . K e l l y — 
Garvet et a l , 1973 — 48). 
According to data published by R . Shram in 1974, the mutagenic ac t iv i ty 
of aminazine is manifested on cell cultures from mammals and man, and on 
microorganisms upon metabolic act ivat ion, whereas insofar as dominant le-
thal mutations in mammals are concerned, the results are rather controversial 
( N . P . Bochkov, R . Y . Shram et a l , 1975 — 5) . 
Regarding the effect of chlorpromazine on the fetus during treatment of 
pregnant women, reports are avai lable (cited by 31) both on hyperbi l i rubinemia 
in the newborns ( P . Scokel et a l , 1962 and V . Apgar 1964), and absence of 
relationship whatever between icterus neonatorum and C P ( A . Belmont et al 
1963). Out of a total of 52 women receiving more than 500 mg C P dai ly during 
the last months of pregnancy, s t i l lb i r ths are recorded in two cases, abor-
t i o n — in one, and convulsive seizures — in one ( D . Sobel, 1960). Also , a 
ch i ld w i th congenital monstruosity is observed ( J . L . and J . A . O ' L e a r y , 1964). 
I n the first cytogenetic investigation of schizophrenic patients in this 
country, M . Tzoneva, L . Ivanov and B . Petrov(1965 — 2 9 ) establish a predi-
sposition to chromosome deletions, thereafter assuming (1967 — 59) that the chan-
ges recorded i n the karyotype maybe due to secondary factors, the application 
©f simultaneous neuroleptic treatment inclusive. I n a subsequent study of 
schizophrenic patients, L . Ivanova and D . Boneva (1967 —13) found that 
patients undergoing C P treatment have a greater number of chromosome aber-
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ations thereby presuming that chlorpromazine could be accepted as the caus-
ing factor of their occurrence. Dur ing the same year, M . Cohen et al repea-
tedly reported on an increased number of chromosome deletions in the course 
of C P treatment (1967 — 3 4 , 35). K . Hirschhorn and M . Cohen (1968 — 42), 
J . Nielsen et a l (1969 — 52), E . Jenk ins (1970 — 45) described analogical find-
ings. M . Cohen et a l also published in 1969 and 1972 (36, 38) their own, and 
those of A . Sandberg (cited by 36), negative cytogenetic results among pa-
tients undergoing C P treatment. I n 15 schizophrenic patients treated wi th phe-
nothiazines (without specification of the preparations) and other neuroleptics, 
V . Ionchev, M . Tzoneva, M . Krachunova and G . Va lkova (1975—15) found 
unreliable increase in structural aberrations, as compared to a group of un-
treated patients. Using the method of Moorhead et a l , as modified by M . Tzo-
neva 1967 — 28), L . Ivanova and D . Boneva (1973 — 43) studied lymphocyte 
cultures from 21 patients wi th schizophrenia and other affections prior to and 
after C P treatment for one month. Their findings point to a dose-related in-
crease in chromosome breaks. 
I n lymphocyte cultures treated in vi tro wi th C P , M . Cohen et al (1969 — 
36) and N . Kamada et al (1971 — 4 6 ) failed to observe chromosome aberrations. 
L . Ivanova and D . Boneva (1973 — 43) established a significant increase in 
structural aberrations upon administration of 5 mcg/ml C P for 72 hours to 
cultures from 21 healthy individuals and patients wi th psychogenic and schi-
zophrenic conditions. I n compliance wi th data published by R . Shram (1974 —-
cited by 5) , the results of aminazine treated lymphocyte cultures are conflict-
ing. Reports by O. Rendon (1974—55) on the effect of chlorpromazine in 
vi t ro , and by V . S. Zhurkov (1975—12) in terms of aminazine are negative. 
The brief survey of literature data on the issue shows that there are a great 
number of dissenting results concerning the mutagenic action of phenothiazi-
nes, chlorpromazine in part icular, and in most instances it is a matter of 
uncomparable findings because of differences in the methods employed. I n 
lymphocyte cultures treated in vi t ro , the differences involve main ly the meth-
od and length of cul t iva t ion, as wel l as the concentration and duration of 
C P treatment. Experience had to date shows that colchicine is toxic for cells 
whenever administered at dose exceeding 0.5 mcg/ml (after the method of 
P . Moorhead et a l , 1960 — 51); in 72-hour cultures, most of the cells are already 
in the second phase of mitosis, and the number of aberrations which occurred 
during the first mitosis (by the 54th hour) is altered ( K . Bakton , G . Evans , 
1975— 1). I t is pointed out that prolonged mutagen exposure is inexpedient, 
on the one hand, owing to the fact that its concentration is altered as the re-
sult of spl i t t ing, and on the other, because it acts in different stages of the 
mitotic cycle ( K . N . Yakovenko et a l , 1974 — 3 2 ) at appreciably modified sen-
s i t i v i t y ( N . P . Bochkov, 1975 — 4) . 
The facts outlined above led us to undertake a comparative study on the 
effect of chlorpromazine on lymphocyte cultures, using different methods and 
time of cu l t iva t ion , as wel l as different treatment periods and concentrations 




Material and method 
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Lymphocyte cultures from the venous blood of fourteen healthy indi­
viduals (5 women and 9 men) wi th average age 29 years, were investigated. 
Par t of each culture was set apart as a control ( K ) . The remainder was distr i­
buted into experimental setups w i t h addition of sterile solution of C P sub­
stance in physiological saline. E a c h setup was processed in 2—3 parallel re­
peats. Nutrient medium 199 "Pasteur" without additives and aeration was 
used. Colchicine treatment lasted for three hours. The preparations were 
stained after Giemsa. 
B y mode of work, the investigations performed were divided up into four 
groups. I n the first the cul t ivat ion was done after the method of Moorhead 
et a l , as modified by M . Tzoneva (28), using the phytohemagglutinin of Tzo-
neva. Colchicine at dose 10 mcg/ml was administered, and hypotonic process­
ing was made wi th disti l led water. I n the other three groups 0.5 mcg/ml col­
chicine, 0.555 per cent potassium chloride as hypertonic solution (1) and phy­
tohemagglutinin ttNlEM" were ut i l ized. 
Thus the following groups were established: 
Group I — four individuals , cu l t iva t ion term — 72 hrs. Experiment wi th 
5 mcg/rnl C P for 72 hrs; 
Group I I — four individuals , cul t ivat ion term 72 hrs. Experiments wi th 
5 mcg/ml C P for 72, 48,24 and 4 hours, administered accord­
ingly at 0, 24, 48 and 68 hours; 
Group I I I —two individuals , cul t iva t ion term 72 hrs. Experiments wi th 
50 mcg/ml C P for 4, 24 and 72 hrs; 
Group I V — four individuals , cu l t iva t ion term 56 hrs. Experiments wi th 
50 mcg/ml C P for 4, 32 and 56 hrs, administered at 0,24 and 
52 hrs. 
Metaphase plates wi th adequately scattered and clearcut chromosomes, 
displaying moderate spiralization, diploid (44—47 chromosomes) or tetra-
ploid, one hundred per setup, were subjected to cytogenetical study. Metapha-
ses not exceeding 25 from two coded preparations each were picked out from 
each duplication. Analys i s of a total of 5000 metaphases was made under mic­
roscope, photographing only those w i th aberrations, except for group I where 
a l l metaphases were photographically recorded. Cells without karyotyping and 
chromosomes wi th breaks and reorganizations, as wel l as cells w i th associa­
tions of acrocentric chromosomes, and chromosomes participating in the lat­
ter were recorded by number and type. Achromatic disorders without dislo­
cation of chromatids were not included. 
To perform the immunomorphologic study, 5000 in group I , and 2000 
cells each per experimental setup in the other groups were differentially coun­
ted from the same preparations, totall ing 124 000 cells . Apart from blast 
and mitotic index ( B I , M I ) , tetraploid mitoses and amitoses were also recorded. 
The results from the cultures experimented upon were subjected to intra-
group comparison wi th those from the control cultures to assay the effect of 
C P . Intergroup comparison of control cultures was made wi th due considera­
tion to the different conditions of cu l t iva t ion . 
Sta t is t ical elaboration was performed using the methods of var ia t ion and 
alternative analysis ( D , Sepetliev, 1972—25). 
Cytogenetic^ and immunomorphological study of.. 75. 
Results 
Aneuploidy does not show significant changes in any of the experimental 
setups w i th C P treatment. 
Structural aberrations ( F i g . 1) in group I show a reliable increase, wi th 
the percentage of damaged cells r is ing from 3.50 to 19.50, and the average aber­
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Fig. 1: Chromosome aberrations. 
I n group I I and I I I , the 72-hour-long incubation does not account for 
noteworthy differences both upon treatment-with 5 and 50 mcg/ml C P . The 
percentage of aberrant cells alters accordingly from 2.00 (1.50) to 2.25 (3.00). 
lnsignficant are l ikewise the differences in the mean number of breaks per-
100 cells . The same holds true for the experiments wi th 4-, 24- and 48-hour-
long C P treatment at dose 5 mcg/ml, as wel l as wi th 50 mcg/ml C P for 24 hours. 
O n l y upon 4-hour treatment wi th 50 mcg/ml C P (group I I I ) , the percentage 
of cells wi th breaks, and the average number of breaks per 100 cells augment 
r e l i ab ly from 1.50 to 5.00 and 6.00 respectively (p <0 .005 ) . 
I n none of the experiments w i th 56-hour cul t iva t ion (Group I V ) are re l i ­
able differences established in terms of aberrations in comparison wi th the 
controls. 
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[Structural aberrations in the control cultures present deletions of onechro* 
matid and four isochromatid fragments altogether in group I and I I . I n part 
of the experiments in group I I (24 hrs) and group I V (56 hrs) only monochroma-
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Fig. 2: Percentage of cells with associations. 
quency next rank paired acentric fragments and seven centromere divis ions 
in a l l . The least are the reorganizations yielded by a total of four dicentric 
chromosomes in 3 cells for a l l experimental setups. 
The associative capacity of acrocentric chromosomes estimated by the 
percentage of cells wi th associations, average number of associations per cel l , aver-
age number of associated chromosomes per ce l l , and the percentage of associated 
chromosomes D and G (relative to their total number) in treated cultures is 
inhibited. A n exception in this respect is the 48-hour experiment in group 
I I where the values of the indicators augment, rather considerably for the aver-
age associations and associated chromosomes per ce l l . I n the other e x p e r i -
ments the values of the five indicators listed above decrease, although not 
always re l iab ly . Th i s is most strongly pronounced i n group I I I , where o n l y 
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е percentage of associated D chromosomes shows an insignificant difference 
__t 24 hours. Upon 72-hour treatment in group I I , s imi la r ly only the percentage 
of D chromosomes is not s ignif icantly diminished. I n group I V the percentage 




















































Fig . 3: Immunoproliferative activity. 
associations and associated chromosomes in the average per cell — upon 56 
and 32-hour treatment. I n group I , a l l the values decrease insignificantly. 
Changes in the percentage of cells _with associations, and its values are 
' l lustrated in F i g . 2. I n group I I , it decreases significantly only in the 72-
our experiment, whi le in group I I I and I V — in a l l experimental setups. 
The average associations per cel l which in the controls are 0.925 (group I ) , 
1.440 ( I I ) , 1.455 ( I I I ) and 1483 ( I V ) do not decrease significantly in group I , 
as wel l as in group I I — on 48- and 24-hour treatment, and in group I V — 
on 4-hour treatment. 
The number of associated chromosomes in the average per cell — 2050 
(group I ) , 3.305 ( I I ) , 3.320 ( I I I ) and 3.520 ( I V ) — displays a modification 
parallel to the average associations per ce l l . 
The percentage of associated chromosomes D — 18.17 ( I ) , 28.04 (11), 
30.67 ( I I I ) and 35.21 ( I V ) — decreases re l iably only upon 72- and 4-hour treat­
ment w i th 50 mcg/ml C P (group I I I ) . 
The percentage of associated chromosomes G — 24.00 ( I ) , 40.56 ( I I ) , 
37.00 ( I I I ) and 35.19 ( I V ) — shows a stronger reduction than the percentage 
1 
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of D , significant in the 72-hour setup of group I I , and in a l l experimental set­
ups in group I I I . 
Blas t ac t iv i ty is significantly modified in part of the experiments and 
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F i g . 4 and 5: Comparison of untreated cultures. 
5 mcg/ml C P , i t decreases after-treatment for 72 hrs (gr. I and I I ) and 48 hrs 
( I I ) , whereas upon 24-hour treatment it increases, and on 4-hour treatment it 
remains unchanged ( I I ) . Treatment w i th 50 mcg/ml causes blast ac t iv i ty re­
duction only after shorter exposures — 24 and 4 hours ( I I I ) . I n 56-hour cu l ­
tures there is no ieduction whatsoever, while the 32-hour experiment displays 
a significantly higher B I . 
Mitotic ac t iv i ty (F ig . 3) does not follow the course of changes in blast 
ac t iv i ty . I n the longest exposures M I decreases singnificantly in a l l groups ex­
cept for group I , the latter corresponding to a change in blast index in group 
I I alone. I n the 24-hour experiment M I in group I I is lowered at parallel in­
crease in B I , whi le in 24- and 4-hour treatment ( I I I ) , it augments contrary 
to B I reduction. 
Tetraploid mitoses exhibi t a significant change only in group I where 
they are substantial ly increased — from 0.00 to 0.51 per cent (p < 0.001). 
Inasmuch as the percentage of cells in amitotic division shows significant 
changes (only in groups I I I and I V ) , i t should be pointed out that they are 
opposing and do not correlate wi th the changes in B I and M I . 
A comparison between the groups is made for some of the indicators of 
the control setups (Figs. 4 and 5) . I n the comparative study, the results for 
group I I and I I I are summed up (group I I — I I I ) since C P concentration is the 
only difference between the 72-hour cultures, whereas group I V is wi th 56-
hour cul t iva t ion , and group I differs from the remainder by the way of treat­
ment. 
Group I is distinguished by the highest number of chromosome breaks, 
least associations, average%blast ac t iv i ty and highest mitotic ac t iv i ty . I t should 
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be streassed that the greater M I in group I is largely attributed to mitoses 
hardly lending themselves to cytogenetic analysis , whi ls t in the other groups 
metaphases wi th a perfect morphology predominate. The percentage of cells 
wi th aberrations and aberrations per one hundred cells exceed those in group 
I I — I I I , but differ re l iably from group I V alone. The percentage of cells wi th 
associations is re l iably lower than that of group I I — I I I and I V . B I in group I dif­
fers essentially both from the highest one in group I I — I I I , and from the low­
est one in group I V . The mitotic index in group I exceeds re l iably M I in the 
other groups. 
Group I V (56 hrs) is characterized by the smallest mumber of breaks, 
lowest blast and mitotic ac t iv i ty , and most strongly pronounced associative 
capacity of acrocentricytes. B y the signs outlined above it differs essentially 
not only from group I , but also from group I I — I I I , except for the percentage 
of cells wi th associations. 
Discussion 
The research shows that upon treatment of cultures wi th 0.5 mcg/ml col­
chicine for 3 hrs, the addition of C P at dose 5 mcg/ml for 72, 48, 24 and 4 hrs 
(group I I ) , and for 56, 32 and 4 hrs (group I V ) does not produce an increase in 
chromosome aberrations. The great number of chromosome breaks at analo­
gical C P concentrations in cultures treated wi th 10 mcg/ml colchicine (group I ) , 
which concentration is toxic for the cells (1), in our opinion, should be at tr i ­
buted to its combined effect wi th colchicine. The nearly twice as great number 
of breaks in the control cultures at high colchicine concentration — 4 per 
100 cells for group i against 2.33 for group 11-111 — is accepted as an argu­
ment in favour of Ihe above statement. The increase in structural aberrations 
among C P treated cases, observed wi th this particular method of cul t ivat ion 
(43), is most l i k e l y due to the combined action already referred to. However, 
for the time being, we are not in a position to confirm the hypothesis set forth 
wi th comparative data. 
The authors claiming negative results in studies, in vi t ro , use 72-hour 
cultures, treated wi th different C P concentrations: 1 and 10 (12); 1, 10 and 
100 (36); 0 .7 ,3 .5 , 7 .1 , 17.7 and 35 mcg/ml (46), for periods ranging from 6 to 
72 hrs. I n two of the reports there is evidence of 2-hour treatment wi th 0.2 
mcg/ml colchicine (46) or 0.05 mcg/ml colcemide (36) corresponding to about 
0.5 meg colchicine. The C P concentrations under test, those used by us in ­
clusive, cover also the theoretical therapeutical concentration. A t dose 100 
mg four times dai ly, received by an individual weighing 80 kg and blood to­
ta l l ing s ix liters, a concentration up to 16.6 mcg/ml blood may be attained, 
at 5 meg C P per gram body weight dai ly . However, chlorpromazine split t ing 
occurs very rapidly, and wi th in 2 hrs of oral receipt, up to twenty C P metabo­
lites are found in the blood. A t 400 mg daily amount received, eleven of the 
metabolites after summation display values ranging from 0.340 to 0.450 mcg/ml 
(P . K a u l e t a l , 1972 — 47), while C P itself — from 0.105 to 0.336 mcg/ml 
( S . C u r r y , 1970—39). On the other hand, on prolonged use, chlorpromazine depo­
sits unevenly wi th in the tissues, and a concentration of 17.5 mcg/g has been 
established in thegonadsof a deceased patient (Е . M . Solomatin, 1966 — 23). 
According to the cited data, administration in vi tro of doses substantially 
exceeding the realizable therapeutical concentration in the blood or gonads fail­




No data concerning the administration of 50 mcg/ml C P are available. 
A s in treatment with 100 mcg/ml (36), the 50 meg dose too yields a marked 
cytotoxic effect. One of the experimental setups (48-hour treatment), and part 
of the repeats were discarded because of the absence of mitoses suitable for 
cytogenetic analysis. Wherever such an effect was possible, the unfit mitoses 
compact or crushed and slovened chromosomes prevailed unlike control cul -
tures where practically a l l mitoses were adequately scattered, wi th a clear-
cut chromosome pattern. I n a l l treatment terms there were cells wi th par t i a l 
or complete "pulverization" of chromosomes. Hence it is believed that the in -
crease in structural aberrations at four-hour exposure is an expression of a toxic 
•effect. On longer exposure, it is hardly detectable, probably owing to the hea-
vier lesion of cells, rendering them unfit for cytogenetical analysis . The sig-
nificant rise of breaks recorded only after 4-hour treatment — in the G 2 
period — might be related by analogy to the data concerning radiation muta-
genesis (Z. A . Dzhemilev, 1967 — 9; A . V . Sevankaev e t a l , 1973 — 24), as wel l 
as to the greater vulnerabi l i ty of chromosomes at this particular period of the 
mitotic cycle. Although the former explanation seems more ver is imilar , the 
assumption is warranted that in the G 2-period the chromosomes are more v u l -
nerable by chlorpromazine since among cultures treated wi th 5 mcg/ml C P too, 
the breaks are more numerous in the 4-hour exposure setup (p > 0.05). 
We recorded changes in associations of chromosomal satellites as an ad-
di t ional cytological indicator in assaying the drug effect (M. Cohen et a l , 1971 — 
37). I t is believed that associations are a very fine indicator for the general 
condition of the chromosome set (A . A . Profjeva-Belgovskaya, 1966— 18), 
and may reflect the immunologic readiness of cells ( V . M . G ind i l i s et a l , 1967—8). 
Presumably, in lymphocyte cultures a l l acrocentrics merge in associations 
( N . S. Zhdanova et a l , 1975— 11) which, larger ones in particular, undergo par-
t ia l destruction or fragmentation depending on the methods used of cu l t iva -
tion and working out of preparations ( N . S. Zhdanova, 1972 — 10). 
I n this study cultures treated wi th 0.5 mcg/ml colchicine have associative 
indices rel iably higher than in group one. Against the background outlined 
their reduction, dependent upon the time of C P treatment and concentration^ 
stands out; in case of longer exposure and higher concentration, such a re-
duction involves mostly small acrocentrics. 
Upon 6-hour cul t ivat ion, associations are the most numerous. Th i s cor-
roborates the report c la iming that in the first metaphase associative indica-
tors are higher than in the second one (10). Their lower values in group I are 
ascribed to the toxic colchicine effect. 
L . Ivanova and D . Boneva (1972—14) found a lowered percentage of 
cells wi th associations following one-month C P treatment of schizophrenic 
patients, whi ls t in lymphocyte cultures treated wi th 10 mcg/ml C P , the aver-
age percentage of associations per cell were also lowered. I n the course of 
psychogeny treatment (using rather low C P doses), and upon administration 
of 5 meg ml C P in vi tro to patients and healthy individuals , noteworthy dif-
ferences in the associative capacity indicators are not manifested (the cul-
tures are treated wi th 10 mcg/ml colchicine). No literature data concerning 
C P behaviour to associations are avai lable . A significant reduction is observ-
ed 8—10 years after acute radiation disease ( N . D . Okladnikova , 1970—17). 
S imi la r findings were described by L . Vas i l eva upon in vi t ro tetracycline 
treatment of lymphocyte cultures, as wel l as by I . V . Georgieva and M . Tzo-
neva (1967—7) — wi th diazinon and lindane. 
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I n 72-hour cultures at 5 rr.cg/ml C P an inhibit ion of b k s t traisformation 
Ирвсогded provided treatment is begun wi th in the first 24 hours. I n 56-hour 
treatment no inhibi t ion is noted. I n 72-hour treatment wi th 50 mcg/ml C P the 
ytotoxic effect was so strong that one of the experimental setups had to be 
discarded. I n the second experiment s imi la r ly a substantial number of dege­
nerated cells were present, but in the preserved ones B I reduction was insig­
nificant in contrast to shorter exposures. Mitotic ac t iv i ty was inhibited upon 
K and 50 mcg/ml C P addition after the start of cul t ivat ion (unreliable in group I 
n l y ) , regardless of the concentration used. 
N . Kamade et a l (46) established that 3.5 to 35.5 mcg/ml C P , added wi th­
in the first 18 hrs of cul t ivat ion, inhibits the blast transfcrmation of l y m -
hocytes. According t o M . Cohen et al (36), 100, 10 and 1 mcg/ml C P account 
or mitosis inhibit ion at linear dependence upon the duration of exposure. 
We observed (1973—2) a reliable reduction of blast and mitotic ac t iv i ty upon 
~2-hour treatment wi th 5, 10 and 15 mcg/ml C P ; such a reduction was not ma­
nifested at 2 meg. I n patients undergoing C P treatment (1974—3), the effect 
was directly related to the dose and continuity of medication: in higher doses 
it resulted in a reduction, and in lower doses — in an increase in B I and M I . 
I n either investigation the effect was rather pronounced in terms of the blast 
index, whereas in terms of mitot ic index substantial individual fluctuations 
were noted. I n the case material reported on the data concerning mitotic acti­
v i t y are in agreement wi th those published by M . Cohen et al (36) and by the 
authors (2) , and concerning blast ac t iv i ty — with N . Kamada 's and our own 
results (45,2). 
The occurrence of polyploidy under C P effect, already observed by us 
earlier, under analogical conditions of cul t iva t ion, both in vitro wi th 5 mcg/ml 
C P , and in treatment using higher drug saturation (2, 3) , was manifested in 
group I alone. Th i s led us to the conclusion that cell division is impaired by 
the combined action of C P and high colchicine concentration. The cited authors 
who studied the C P effect-in v ivo and in vitro on lymphocyte cultures mention­
ed nothing about polyploidy. According to M . Tzoneva and M . Krachunova 
(1972—39), ire&tment wi th neuroleptics exerts a polyploidogenic effect. 
I t should.be emphasized that between the individual groups differences 
exist not merely in terms of the treatment cultures, but also in terms of blanks 
wi th different way of cul t iva t ion . I n group I a major part of the mitoses do 
not lend themselves to cytogenetic analysis . The fact of being compact or in­
sufficiently scattered may be explained by the hypotonic processing wi th dis­
t i l led water, whi ls t the short, thick and smeared chromosomes, in our opinion, 
should be ascribed to the higher colchicine concentrations used. To the latter 
we attribute also the enhanced breakabi l i ty of chromosomes and the reduction 
of associations. Immunoproliferative indicators depend first and foremost on 
the qualities of the stimulator employed. I n this group, treated with, the phy-
tohemagglutinin of prof. M . Tzoneva, the mitotic index is higher, and the 
blast one — lower than in I I — I I I group, subjected to treatment w i th her 
preparation, produced by N I E M (batch one). I n 56-hour cultures where only 
the first cell population is studied, the immunoproliferative indicators are 
the lowest, but chromosome integrity and associations are preserved ad ma­
x imum. Differences in blank cultures of the individual groups attest the great 
impact of the method and cul t iva t ion time on the results, and up to a certain 
extent — the quali ty of the materials employed. 




The blast transformation of cul t ivated lymphocytes is an expression of 
their immunologic response to the st imulant . The established inhibitory ef-
fect of chlorpromazine on the latter response calls our attention to the problem 
of its therapeutical action . V . Ionchev, M . Tzoneva, M . Krachurova and G . V a l -
kova found out that neuroleptics act immunosuppressively, and thus explain-
ed their therapeutical effect in schizophrenia. On the other hand, according 
to the cited authors, the continued treatment wi th high doses leading to cell 
destruction (confirmed also by H . Sommer et a l , 1970—56), creates conditions 
for autoimmunization. 
Blastogenesis is provoked by one of two routes — through fal l ing of the 
st imulant onto the cytoplasm, or through the effect it exerts on the cell sur-
face (M. Radeva , Y . Stoichkov, 1971 —19) . I ts action is instantaneous, but 
nevertheless requires a rather prolonged contact wi th the cell surface where 
it is retained ( A . Y . Friedenstein et a l , 1969—27). I t is wel l known that C P 
inhibits the permeability of cell ( A . Freeman et a l , 1963—41) and mitochond-
r i a l (M. Spirites et a l , 1963—57) membranes, decreases water permeability, 
and influences the passive transport of ions and some organic components. 
Methionine transport is l ikewise inhibited (33). The membranous action of 
chlorpromazine on lymphocytes may explain the inhibit ion of blast transfor-
mation upon treatment w i th in the first 24 hrs of cul t ivat ion, i . e. at the time 
when the stimulant is supposed to trigger transformation. 
Chromosome deletions under the simultaneous effect of C P and colchi-
cine at toxic concentration are most l i ke ly due to the inhibi t ion of cellular 
permeability by chlorpromazine. Presumably, part of the breaks taking place 
in the G x -and S-period of the mitotic cycle, are repaired wi th in 40 hours of 
cul t iva t ion , that is before the G 2 - period (24) — a fact explaining among 
other things the highest number of aberrations upon treatment in the last 
few hours prior to mitosis. I f the transport of constituents, indispensable lor 
the restoration, across the cell membrane is hindered, this in turn would in-
terfere wi th the reparative process itself. I n the latter case the assumption is 
warranted that chlorpromazine potentiates the toxic action of colchicine on 
chromosomes by interfering wi th the transport of ingredients necessary for 
their integrity. I t is furthermore possible that its action is added to that of 
colchicine. B y the way, the work of L . Ivanova (1976—44) who, under equal 
conditions of cul t ivat ion, was successful in demonstrating a different muta-
genic effect, dependent on the dynamics of schizophrenic disease, gives us 
sufficient reason to accept a potentiation of the colchicine effect by the action 
of other mutagenic factors. 
Assessment of the mutagenic ac t iv i ty of drugs is an essential problem, 
especially when it is a matter of extensively and continuously applied prepa-
rations, such as chlorpromazine. Hav ing in mind the impossibil i ty to perform 
direct investigation on humans, it is recommended to extrapolate directly on 
man the positive effect established on any test-object, since underestimation of 
the mutagenic r i sk is more dangerous than its overrating (5). 
Summarizing the data submitted concerning chlorpromazine effect on 
human lymphocyte cultures, in vi t ro, emphasis should be la id on the fact that 
its application at concentrations not exceeding the level required for the at-
tainment of a therapeutical effect, by no means leads to chromosome aberra-
tions. The latter are produced whenever it acts in combination wi th colchi-
cine, at toxic concentration, where the presumption of a mutual drug poten-
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Ц И Т О Г Е Н Е Т И Ч Е С К И Е И И М М У Н О М О Р Ф О Л О Г И Ч Е С К И Е Щ 
И С С Л Е Д О В А Н И Я В Л И Я Н И Я Х Л О Р П Р О М А З И Н А НА 
Л И М Ф О Ц И Т Н Ы Е К У Л Ь Т У Р Ы В П Р О Б И Р К Е ОТ Ч Е Л О В Е К А 
Д. Бонева 
Р Е З Ю М Е 
Проведено сравнительное исследование действия хлорпромазина (ХП) 
на лимфоцитные к у л ь т у р ы от 14 здоровых лиц , распределенные на 4 экспе­
риментальные группы. Исследованы цитогенетически 5000 метафаз , а им-
муноморфологически — 124 000 клеток . Неодинаковые условия культиви­
рования приводят , как в контрольных , т а к и в третированных Х П к у л ь ­
т у р а х к в ы р а ж е н н ы м р а з л и ч и я м . При применении Х П в дозах 5 мкг /мл , 
что превышает осуществимый терапевтически уровень в крови , поврежда­
ется хромосомная структура , только если в то ж е время имеется к о л х и ц и и и 
в высокой концентрации , при которой увеличиваются хромосомные аберации 
и в контрольных к у л ь т у р а х . Это может быть объяснено суммированием и х 
действия , но более вероятным я в л я е т с я , что Х П потенцирует мутагенное 
действие колхицина , т а к к а к подобный эффект на колхицин наблюдался и 
под в л и я н и е м другого фактора . 
На основании экспериментальных д а н н ы х обсуждается терапевтиче­
ское действие Х П на иммунный ответ и ставится вопрос о возможном риске 
потенцирования мутагенеза при медикаментозной полипрагмазии . 
